alpha-aminopyridine has been researched along with Recrudescence in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 16 (55.17) | 24.3611 |
| 2020's | 7 (24.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JJ; Gu, JJ; Guo, WJ; Li, R; Li, XY; Liu, YZ; Sun, XJ; Wang, L; Wu, JC; Xu, CH; Xue, K; Zhang, JY; Zhang, QL | 1 |
| Carayannopoulos, L; Cheng, Y; Li, Y; Reyes, J; Tong, Z; Wang, X; Zhou, S | 1 |
| Egeberg, A; Gyldenløve, M; Meteran, H; Zachariae, C | 1 |
| Barriga, S; Bear, MM; Bouabdallah, K; Buchanan, S; de Guibert, S; Gelbert, LM; Hess, G; Li, L; Li, LQ; Morschhauser, F; Prasad Kambhampati, SR; Stilgenbauer, S; Thieblemont, C; Turner, KP; Wilhelm, M; Zettl, F | 1 |
| Fang, JP; Han, XW; Huang, K; Li, XY; Xu, LH; Zhang, YT | 1 |
| Campone, M; Chinot, O; Clement, PM; DeGroot, J; Donnet, V; El-Hashimy, M; Gan, H; Gil-Gil, MJ; Idbaih, A; Mason, W; Mills, D; Pineda, E; Raizer, J; Rosenthal, M; Wen, PY | 1 |
| Baek, JJ; Deveau, CM; Kline, H; Yamamoto, BK | 1 |
| Bussel, JB; Lee, EJ; McDonald, V; Newland, A | 1 |
| Barca, EG; Barrigon, DC; Bociek, RG; Gerecitano, J; Kim, WS; Kong, O; Martinelli, G; Pisal, CB; Salles, G; Tavorath, R; Turgut, M; Younes, A | 1 |
| Giovannini, M; Niscola, P; Scaramucci, L | 1 |
| Stein, EM | 1 |
| DiNardo, C | 1 |
| Roboz, GJ | 1 |
| Bansal, P; Bhatia, R; Dogra, R; Rawal, RK; Shankar, R | 1 |
| Camidge, DR; Honce, JM; Lindquist, DL; Sakamoto, MR | 1 |
| Beyene, J; Danska, JS; Grandal, I; Guidos, CJ; Hitzler, JK; Kowalski, PE; Matei, IR; Minden, MD; Nutter, LM; Papp, E; Perova, T | 1 |
| Bashir, A; Bollag, G; Burton, EA; Carias, H; Damon, LE; Habets, G; Hsu, HH; Ibrahim, PN; Kasarskis, A; Lasater, EA; Le, MH; Lin, KC; Massi, E; Matusow, B; Pendleton, M; Perl, A; Powell, B; Sebra, R; Shah, NP; Shellooe, R; Smith, CC; Spevak, W; Tsang, G; West, BL; Zhang, C; Zhang, J; Zhang, Y | 1 |
| Noori, HR; Spanagel, R; Vengeliene, V | 1 |
| Ardeshna, KM; Bartlett, NL; Blum, KA; Flinn, IW; Flowers, CR; Friedberg, JW; LaCasce, AS; Mitchell, P; Shustov, AR; Skolnik, JM; Thress, KS; Zheng, F | 1 |
| Gadicherla, S; Pentapati, KC; Smriti, K | 1 |
| Arnaud, A; Berton-Rigaud, D; Fabbro, M; Favier, L; Floquet, A; Foa, C; Heudel, PE; Joly, F; Kalbacher, E; Kaminsky, MC; Lesoin, A; Lortholary, A; Meunier, J; Priou, F; Ray-Coquard, I; Roche-Forestier, S; Roemer-Becuwe, C; Selle, F; Tazi, Y; Treilleux, I; You, B | 1 |
| Bai, O; Cai, Z; Chen, X; Ding, K; Dong, M; Gao, Y; He, H; Hou, M; Huang, H; Huang, X; Jia, B; Jin, J; Jin, Z; Li, W; Li, X; Li, Z; Liang, R; Liu, L; Liu, P; Liu, Q; Liu, T; Luo, J; Luo, Y; Qiu, L; Shen, J; Shi, Y; Song, Y; Su, H; Su, L; Sun, X; Sun, Z; Tan, H; Tang, X; Wang, H; Wang, J; Wang, S; Wang, X; Wu, G; Wu, J; Xu, J; Xu, W; Yang, H; Yang, J; Yi, P; Zeng, Q; Zhang, H; Zhang, L; Zhang, X; Zhang, Y; Zhang, Z; Zhao, W; Zhou, D; Zhou, J | 1 |
| Chen, Q; Chen, R; Dong, Y; Gao, F; Jiang, L; Lin, M; Liu, J; Meng, W; Wang, Z; Xu, T; Zeng, X; Zhong, X; Zhou, H | 1 |
| Biagioni, PA; Lamey, PJ; Murray, B | 1 |
| Greer, RO; Juarez, T; Khandwala, A; Lindenmuth, JE | 1 |
| Dierkes-Globisch, A; Mohr, HH; Schäfer, R | 1 |
| Eisen, D; Lynch, DP | 1 |
| Camarasa, JG | 1 |
5 review(s) available for alpha-aminopyridine and Recrudescence
| Article | Year |
|---|---|
Fostamatinib for persistent/chronic adult immune thrombocytopenia.
Topics: Adult; Aminopyridines; Blood Platelets; Chronic Disease; Humans; Immunotherapy; Morpholines; Oxazines; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Recurrence; Signal Transduction; Syk Kinase | 2018 |
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia.
Topics: Aminopyridines; Antineoplastic Agents; Enzyme Inhibitors; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Recurrence; Triazines | 2018 |
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide | 2016 |
[Asymptomatic diclofenac-induced acute hepatitis].
Topics: Acute Disease; Aminopyridines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Diclofenac; Drug Therapy, Combination; Humans; Liver; Male; Middle Aged; Pain, Postoperative; Recurrence | 2000 |
Selecting topical and systemic agents for recurrent aphthous stomatitis.
Topics: Administration, Topical; Aminopyridines; Anti-Inflammatory Agents; Humans; Prednisone; Recurrence; Stomatitis, Aphthous | 2001 |
9 trial(s) available for alpha-aminopyridine and Recrudescence
| Article | Year |
|---|---|
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study.
Topics: Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Recurrence; Treatment Outcome | 2021 |
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Morpholines; Phosphatidylinositol 3-Kinases; Recurrence | 2020 |
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Remission Induction; Salvage Therapy | 2017 |
Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Bone Marrow Cells; Cell Differentiation; Disease-Free Survival; Female; GTP Phosphohydrolases; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Membrane Proteins; Middle Aged; Mutant Proteins; Mutation; Recurrence; Triazines | 2018 |
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Intracellular Signaling Peptides and Proteins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Morpholines; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Recurrence; Syk Kinase; Time Factors; Treatment Outcome; United States | 2016 |
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
Topics: Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Neoplasms; Female; Humans; Middle Aged; Morpholines; Neoplasm Recurrence, Local; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Treatment Outcome | 2017 |
A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.
Topics: Adhesiveness; Administration, Oral; Aminopyridines; Anti-Allergic Agents; China; Double-Blind Method; Drug Administration Schedule; Humans; Pain; Pain Measurement; Recurrence; Stomatitis, Aphthous; Tablets; Treatment Outcome | 2009 |
The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration.
Topics: Administration, Topical; Adult; Aminopyridines; Anti-Allergic Agents; Body Temperature; Double-Blind Method; Erythema; Female; Humans; Male; Mouth Mucosa; Pain; Placebos; Recurrence; Safety; Stomatitis, Aphthous; Thermography; Time Factors; Treatment Outcome; Wound Healing | 2006 |
A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aminopyridines; Anti-Inflammatory Agents; Double-Blind Method; Drug Tolerance; Erythema; Humans; Middle Aged; Ointments; Pain; Patient Compliance; Placebos; Recurrence; Stomatitis, Aphthous | 1993 |
15 other study(ies) available for alpha-aminopyridine and Recrudescence
| Article | Year |
|---|---|
Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.
Topics: Aminopyridines; Animals; Apoptosis; Autophagosomes; Autophagy; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Forkhead Box Protein O1; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Male; Mice, Nude; Middle Aged; Neoplasm Proteins; Recurrence; Up-Regulation | 2021 |
Assessment of Transporter-Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients With Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Topics: Aged; Aminopyridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Digoxin; Drug Interactions; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Membrane Transport Proteins; Myelodysplastic Syndromes; Neoplasm Proteins; Pharmaceutical Preparations; Recurrence; Rosuvastatin Calcium; Triazines | 2022 |
Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy.
Topics: Aminopyridines; Benzamides; Cyclopropanes; Humans; Recurrence; Stomatitis, Aphthous | 2022 |
[Preliminary Study of Chidamide Combined with Hematopoietic Stem Cell Transplantation in the Treatment of Childhood Acute T-Lymphoblastic Leukemia].
Topics: Aminopyridines; Benzamides; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Transplantation, Homologous | 2020 |
Roflumilast treatment during forced abstinence reduces relapse to methamphetamine seeking and taking.
Topics: Aminopyridines; Amphetamine-Related Disorders; Animals; Benzamides; Central Nervous System Stimulants; Cyclopropanes; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Phosphodiesterase 4 Inhibitors; Rats; Recurrence; Self Administration | 2022 |
Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia.
Topics: Aminopyridines; Clinical Trials, Phase III as Topic; Humans; Morpholines; Oxazines; Prodrugs; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Pyrimidines; Recurrence; Syk Kinase | 2018 |
Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutation.
Topics: Aminopyridines; Antineoplastic Agents; Biomarkers, Tumor; Clinical Trials, Phase I as Topic; Enzyme Inhibitors; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Multicenter Studies as Topic; Mutation; Prognosis; Recurrence; Research; Treatment Outcome; Triazines | 2018 |
Enasidenib for relapsed/refractory acute myeloid leukemia with IDH2 mutations: optimizing the patient experience.
Topics: Administration, Oral; Aminopyridines; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Gene Expression Regulation, Neoplastic; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Prognosis; Recurrence; Remission Induction; Survival Analysis; Triazines | 2018 |
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
Topics: Adult; Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Central Nervous System; Crizotinib; Drug Approval; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Neoplasm Metastasis; Organophosphorus Compounds; Pyrazoles; Pyrimidines; Recurrence; Treatment Outcome | 2019 |
Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Topics: Administration, Oral; Adult; Aminopyridines; Animals; Cell Proliferation; Cell Survival; Child; Female; Humans; Intracellular Signaling Peptides and Proteins; Leukemia; Male; Mice; Mice, SCID; Morpholines; Mutation; Neoplasm Transplantation; Niacinamide; Oligonucleotide Array Sequence Analysis; Oxazines; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Recurrence; Signal Transduction; Spleen; Syk Kinase; Treatment Outcome | 2014 |
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; fms-Like Tyrosine Kinase 3; Heterografts; Humans; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Molecular Conformation; Mutation; Phenylurea Compounds; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Pyrroles; Recurrence; Structure-Activity Relationship | 2015 |
Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.
Topics: Acetamides; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Aminopyridines; Animals; Choice Behavior; Circadian Rhythm; Disease Models, Animal; Indoles; Male; Melatonin; Motor Activity; Rats, Wistar; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Low-level laser therapy versus 5% amlexanox: a comparison of treatment effects in a cohort of minor aphthous ulcers patients-a commentary.
Topics: Aminopyridines; Humans; Low-Level Light Therapy; Pain Measurement; Recurrence; Stomatitis, Aphthous | 2016 |
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzamides; China; Disease-Free Survival; Fatigue; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2017 |
Analgesic spray contact dermatitis.
Topics: Adult; Aminopyridines; Dermatitis, Contact; Female; Humans; Middle Aged; Patch Tests; Recurrence; Salicylates | 1990 |